Jingyu Yu
3PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
|Sep 04, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.Michael H Brave, William F Maguire, Chana Weinstock
|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer.Asma Dilawari, Mirat Shah, Gwynn Ison
Pageof 1
Frequent Collaborators
3 joint publications
Laleh Amiri-Kordestani
3 joint publications
Shenghui Tang
3 joint publications
Richard Pazdur
3 joint publications
Paul G Kluetz
3 joint publications
William F Pierce
2 joint publications
Mirat Shah
2 joint publications
Mallorie H Fiero
2 joint publications
Junshan Qiu
2 joint publications
Nam Atiqur Rahman
2 joint publications
Tiffany K Ricks
